44例小肠克罗恩病的临床特征

龙美春; 张敏; 姚玲娜; 彭雅; 郭勤

doi:10.11817/j.issn.1672-7347.2021.190732

您当前的位置：

首页 >

文章列表页 >

44例小肠克罗恩病的临床特征

扫描看全文

文章被引用时，请邮件提醒。

提交

论著 | 更新时间：2022-04-07

44例小肠克罗恩病的临床特征
Clinical features of 44 patients with small bowel Crohn’s disease
中南大学学报(医学版) 中南大学学报(医学版) 2021年46卷第10期页码：1109-1113
作者机构：

中南大学湘雅三医院消化内科，长沙 410013
作者简介：

龙美春，Email: dmccllzz@163.com, ORCID: 0000-0002-5541-2884
郭勤，Email: xyldgq@126.com, ORCID: 0000-0001-5785-8372
基金信息：
DOI：10.11817/j.issn.1672-7347.2021.190732
中图分类号：
CSTR：
纸质出版日期： 2021-10-28 ，

收稿日期： 2019-10-22 ，

龙美春, 张敏, 姚玲娜, 彭雅, 郭勤. 44例小肠克罗恩病的临床特征[J]. 中南大学学报(医学版), 2021, 46(10): 1109-1113.

LONG Meichun, ZHANG Min, YAO Lingna, PENG Ya, GUO Qin. Clinical features of 44 patients with small bowel Crohn's disease[J]. Journal of Central South University. Medical Science, 2021, 46(10): 1109-1113.
龙美春, 张敏, 姚玲娜, 彭雅, 郭勤. 44例小肠克罗恩病的临床特征[J]. 中南大学学报(医学版), 2021, 46(10): 1109-1113. DOI：10.11817/j.issn.1672-7347.2021.190732

LONG Meichun, ZHANG Min, YAO Lingna, PENG Ya, GUO Qin. Clinical features of 44 patients with small bowel Crohn's disease[J]. Journal of Central South University. Medical Science, 2021, 46(10): 1109-1113. DOI：10.11817/j.issn.1672-7347.2021.190732

摘要

目的

目前国内外对回肠末端、结肠型克罗恩病的研究较多，但单独对于小肠克罗恩病的研究很少。本研究分析小肠克罗恩病的临床特征及治疗效果，以加强对小肠克罗恩病的诊治。

方法

连续纳入2015年7月1日至2018年10月31日在中南大学湘雅三医院消化内科住院的小肠克罗恩病患者，收集患者人口学和临床资料进行分析。

结果

纳入小肠克罗恩病患者44例，其中男40例；年龄(35.8±10.3)岁；病程(35.2±59.5)个月。病变部位：回肠29例(65.9%)，空肠7例(15.9%)，回肠+空肠8例(18.2%)。疾病行为：狭窄型27例(61.4%)，穿透型4例(9.1%)，非狭窄非穿透型13例(29.5%)。小肠镜下以狭窄多见(29/85，34.1%)，其次为纵行溃疡(27/85，31.8%)。病理检查结果示非干酪样肉芽肿2例(4.5%)。血红蛋白、红细胞压积、红细胞沉降率在缓解期及活动期差异有统计学意义(

0.05)。起病以腹痛最常见(34/44，77.3%)，随访过程中出现并发症(如肠梗阻)者11例(25.0%)，在服用美沙拉嗪治疗的患者中66.7%出现并发症。

结论

小肠克罗恩病多累及回肠，以狭窄型多见；小肠镜下以狭窄及纵行溃疡多见；血红蛋白、红细胞压积、红细胞沉降率对患者疾病活动度的判断具有参考价值；治疗后并发症以肠梗阻多见；美沙拉嗪治疗小肠克罗恩病效果欠佳。

Abstract

Objective

At present

there are many studies on Crohn’s disease of terminal ileum and colon

but few studies on Crohn’s disease of small intestine alone. This study aims to analyze the clinical features and therapeutic effect of small bowel in adult patients with Crohn’s disease so as to strengthen the diagnosis and treatment for this disease.

Methods

From July 1

2015 to October 31

2018

patients with small bowel Crohn’s disease at Department of Gastroenterology

Third Xiangya Hospital of Central South University

were enrolled. At the same time

patients' demographics and clinical data were collected.

Results

A total of 44 patients were small bowel Crohn's disease. Among them

40 patients were male. The age at diagnosis was (35.8±10.3) years old and disease duration was (35.2±59.5) months. The subtypes included 29(65.9%) of ileum

7(15.9%) of jejunum

8(18.2%) of ileum with jejunum. There were 27(61.4%) of stricture behavior

4(9.1%) of penetrating behavior

and 13(29.5%) of non-stricture and non-penetrating behavior. Endoscopic visible stricture (29/85

34.1%) was common

followed by longitudinal ulcers (27/85

31.8%). Non-caseate granulomatous were found in 2 cases (4.5%). The score of Crohn’s disease activity index was correlated to hemoglobin

hematocrit

and erythrocyte sedimentation rate (all

0.05). Among the most common symptom of abdominal pain (34/44

77.3%)

11 patients (25.0%) developed complications (eg. intestinal obstruction) during the follow-up

and 66.7% of patients treated with mesalazine had complications.

Conclusion

Patients with ileum account for a large proportion in patients with small bowel Crohn’s disease. Stricture is more common in small bowel Crohn’s disease. Stricture and longitudinal ulcer are more common under enteroscopy. Crohn’s disease activity index is correlated to hemoglobin

red blood cell specific volume

and erythrocyte sedimentation rate. The most common complication is intestinal obstruction. Mesalazine is less effective on small bowel Crohn’s disease.

关键词

小肠克罗恩病临床特征

Keywords

small bowelCrohn’s diseaseclinical features

references

Gajendran M, Loganathan P, Catinella AP, et al. A comprehensive review and update on Crohn’s disease[J]. Dis Mon, 2018, 64(2): 20-57.

吴开春, 梁洁, 冉志华, 等. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813.

WU Kaichun, LIANG Jie, RAN Zhihua, et al. The consensus on diagnosis and management of inflammatory bowel disease (2018·Beijing)[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(9): 796-813.

Cui GL, Yuan A. A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease[J]. Front Med (Lausanne), 2018, 5: 183.

Chan WPW, Mourad F, Leong RW. Crohn’s disease associated strictures[J]. J Gastroenterol Hepatol, 2018, 33(5): 998-1008.

Kim OZ, Han DS, Park CH, et al. The clinical characteristics and prognosis of Crohn’s disease in Korean patients showing proximal small bowel involvement: results from the CONNECT study[J]. Gut Liver, 2018, 12(1): 67-72.

Thia KT, JrLoftus EV, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia[J]. Am J Gastroenterol, 2008, 103(12): 3167-3182.

Hu PJ. Inflammatory bowel disease in Asia: the challenges and opportunities[J]. Intest Res, 2015, 13(3): 188-190.

Kopylov U, Yung DE, Engel T, et al. Fecal calprotectin for the prediction of small-bowel Crohn’s disease by capsule endoscopy: a systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2016, 28(10): 1137-1144.

Stawczyk-Eder K, Eder P, Lykowska-Szuber L, et al. Is faecal calprotectin equally useful in all Crohn’s disease locations? A prospective, comparative study[J]. Arch Med Sci, 2015, 11(2): 353-361.

Gauss A, Geiss T, Hinz U, et al. Quality of life is related to fecal calprotectin concentrations in colonic crohn disease and ulcerative colitis, but not in ilealcrohn disease[J]. Medicine (Baltimore), 2016, 95(16): e3477.

Yang L, Ge ZZ, Gao YJ, et al. Assessment of capsule endoscopy scoring index, clinical disease activity, and C-reactive protein in small bowel Crohn’s disease[J]. J Gastroenterol Hepatol, 2013, 28(5): 829-833.

Mitselos IV, Katsanos KH, Tatsioni A, et al. Association of clinical and inflammatory markers with small bowel capsule endoscopy findings in Crohn’s disease[J]. Eur J Gastroenterol Hepatol, 2018, 30(8): 861-867.

Ooi CJ, Makharia GK, Hilmi I, et al. Asia Pacific Consensus Statements on Crohn’s disease. Part 1: Definition, diagnosis, and epidemiology[J]. J Gastroenterol Hepatol, 2016, 31(1): 45-55.

Lim WC, Hanauer S. Aminosalicylates for induction of remission or response in Crohn’s disease[J]. Cochrane Database Syst Rev, 2010(12): CD008870.

Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn’s Disease[J]. Cochrane Database Syst Rev, 2005(1): CD003715.

Fasanmade AA, Adedokun OJ, Olson A, et al. Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis[J]. Int J Clin Pharmacol Ther, 2010, 48(5): 297-308.

浏览量

150

下载量

CSCD

工具集

关联资源

老年起病克罗恩病的临床特点及远期预后

原发性干燥综合征合并肺动脉高压的临床特征和危险因素

不同起病年龄的1型糖尿病住院患者的临床特征

克罗恩病在双腔气囊全小肠内镜下的表现